Related Experiment Video
Updated: Jul 17, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Molecular mechanisms of apoptosis in the cardiac myocyte
N H Bishopric1, P Andreka, T Slepak
1Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Miami, Florida 33101, USA. nhb@chroma.med.miami.edu
Insights
Programmed cell death (apoptosis) in heart cells can cause cardiomyopathy. Recent research clarifies apoptosis mechanisms, including mitochondrial roles and signaling pathways, offering potential therapeutic targets for heart disease.
Area of Science:
- Cardiovascular Biology
- Cell Death Research
- Molecular Cardiology
Background:
- Apoptosis of cardiac myocytes contributes to cardiomyopathy and mortality.
- Targeting apoptosis may offer therapeutic benefits for ischemic heart disease and heart failure.
Purpose of the Study:
- To review recent advancements in understanding cardiac myocyte apoptosis.
- To highlight potential therapeutic interventions for heart conditions involving cell death.
Main Methods:
- Review of recent scientific literature on cardiac apoptosis.
- Analysis of signaling pathways involved in myocyte cell fate.
Main Results:
- Enhanced understanding of mitochondria-initiated apoptosis in cardiac myocytes.
- Identification of factors inducing apoptosis during hypoxia.
- Clarification of dual roles (pro- and anti-apoptotic) of hypertrophic stimuli.
- New insights into the roles of MAP kinases (p38, ERK, JNK) in cardiac cell death.
- Further evidence supporting the role of apoptosis in human heart disease.
Conclusions:
- Cardiac myocyte apoptosis is a significant factor in heart disease pathogenesis.
- Mitochondrial pathways and specific signaling molecules (MAP kinases) are key targets for future therapies.
- Further research is needed to validate apoptosis-targeting therapies for clinical benefit.
Abstract:
Cardiac myocytes can undergo programmed cell death in response to a variety of insults and apoptotic elimination of myocytes from the adult myocardium can lead directly to cardiomyopathy and death. Although it remains to be shown that therapy specifically targeting apoptosis will improve the prognosis of ischemic heart disease or heart failure, a number of studies in the past year have shed light on potential ways to intervene in the process. Progress in the past year includes a better understanding of the importance of mitochondria-initiated events in cardiac myocyte apoptosis, of factors inducing apoptosis during hypoxia, and of the dual pro-apoptotic and anti-apoptotic effects of hypertrophic stimuli such as beta-adrenoceptor agonists, nitric oxide and calcineurin. Further evidence supports the pathophysiologic relevance of apoptosis in human heart disease. The tracking of cytoprotective and apoptotic signal transduction pathways has revealed important new insights into the roles of the mitogen-activated protein (MAP) kinases p38, extracellular signal regulated kinase (ERK) and c-Jun N-terminus kinase (JNK) in cardiac cell fate.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

